China
WestGene Achieves FDA Approval for World's First EB Virus-Related mRNA Cancer Vaccine, WGc-043
WestGene, a biotech company dedicated to mRNA technology, announces a historic milestone with the FDA IND approval of its mRNA therapeutic cancer vaccine, ...
May 13, 2024 | News
NeuShen Therapeutics Begins Phase I Trial of NS-136, a Potential Breakthrough in Schizophrenia Treatment
NeuShen Therapeutics , a clinical-stage global biotechnology company dedicated to pioneering treatments for neurological and psychiatric disorders, today a...
May 10, 2024 | News
Ribobay Pharma Partners with Cytiva to Launch Pioneering Oligonucleotide Manufacturing Platform in China
Ribobay Pharma, a leading Chinese biopharmaceutical contract research, development, and manufacturing organization (CRDMO) and a spin-off company of Genera...
May 09, 2024 | News
Biocytogen Partners with BioCopy for TCR-Mimic Antibody Development
Biocytogen Pharmaceuticals, a global biotechnology company focused on the discovery of novel antibody-based therapeutics, today announced a TCR-mimic antib...
May 07, 2024 | News
Shineco Launches Innovative Product to Transform Healthcare
Shineco, a provider of technologically advanced healthcare products and services, announced that its subsidiaries Fuzhou Medashan Biotechnology Co., Ltd. a...
May 02, 2024 | News
Chipscreen's Chidamide Receives NMPA Approval for First-Line Treatment of DLBCL with MYC/BCL2 Expression
Shenzhen Chipscreen Biosciences announced that the company's lead innovative product Chidamide (Epidaza®) , an oral subtype-selective histone deacetyla...
May 01, 2024 | News
Jacobio Pharma Reports Promising Phase II Results for Glecirasib in Lung Cancer at ASCO
Jacobio Pharma (1167.HK) announced that the data from the Phase II registrational study of the KRAS G12C inhibitor glecirasib were offically reported at th...
May 01, 2024 | News
WuXi AppTec Reports First Quarter 2024 Financial Results: Solid Performance with Continued Growth in R&D Services
First Quarter 2024 Financial Highlights: Revenue of RMB 7,982 million, with a slight decrease of 1.8% in non-COVID-19 commercial projects, underscoring ...
April 30, 2024 | Company results
Sino Biological Completes $48M Acquisition of Canadian Firm SignalChem Biotech
Sino Biological, Inc. , a biotechnology company listed on the Shenzhen stock exchange subsidiary ChiNext, specializing in biological research reagents...
April 29, 2024 | News
Dizal to Present New Data on Sunvozertinib for Lung Cancer at ASCO 2024
Dizal (SSE:688192), a biopharmaceutical company committed to developing groundbreaking new medicines for the treatment of cancer and immunological diseases...
April 25, 2024 | News
GenFleet Therapeutics Secures FDA Approval for Pioneering Phase III KRAS G12C Inhibitor Trial in Colorectal Cancer
GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, announced US Food and Drug Adm...
April 22, 2024 | News
Teva Validates AJOVY® Efficacy and Safety in China Phase 3 Migraine Trial
AJOVY confirms efficacy in new Phase 3 data significantly reducing the number of migraine days per month All critical efficacy endpoints met significanc...
April 15, 2024 | News
TransThera Sciences Presents Breakthrough Research on Tinengotinib for Advanced Solid Tumors with FGFR1-3 Alterations at AACR 2024
TransThera Sciences, a clinical-stage biopharmaceutical company focused on inventing differentiated drugs for global patients, announced the poster present...
April 15, 2024 | News
BioCity Biopharma's Cancer Therapy BC2027 Gets FDA Nod for Phase 1 Trials
BioCity Biopharma announced that the U.S. Food and Drug Administration (FDA) has cleared the company's Investigational New Drug (IND) application for a Pha...
April 10, 2024 | News
Most Read
- Biotech and Biopharma Industry Trends: What to Watch for in 2024
- Revolutionizing Drug Discovery: 15 AI Companies to Watch in 2024
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2024
- 2024's Biopharma Roadmap: Top 24 Biopharma Trends to Watch in 2024
- Breakthroughs Unveiled: A Year of Groundbreaking Novel Drug Approvals in 2023
- Revolutionizing Tomorrow: Top 24 Emerging Biotech Innovations to Watch in 2024
Bio Jobs
- Leica Microsystems Announces Vacancy for Senior Imaging FPGA Testing Engineer in Singapore
- Glen Godresse Takes Helm as CEO of Menarini Asia-Pacific
- Eva van Pelt Joins Qiagen's Supervisory Board, Bringing a Wealth of Global Leadership Experience in Healthcare and Life Sciences
- Life Sciences Queensland Welcomes Dr. Kym Baker and Dr. Denise Hodge to Board Leadership
- Bayer appoints Nelson Ambrogio as new Head of Radiology Business at Pharmaceuticals Division
- Danaher Careers - Search Global Science and Technology Jobs
- Careers at MERCK Group
- Ajinomoto Bio-Pharma Services Announces Leadership Changes at US Facility
- Veranova Appoints Mike Riley as Chief Executive Officer
- Find your Job at Eppendorf
News
Editor Picks
